Monte Rosa Therapeutics, Inc. (GLUE)
Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
24. 56
+1.4
+6.0449%
$
1.53B Market Cap
- P/E Ratio
- Div Yield
1.22M Volume
-2.4 Eps
$ 23.16
Previous Close 
Want to track GLUE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Monte Rosa Therapeutics, Inc. (GLUE) Statistics
Valuation metrics
Market Cap 1.53B
Enterprise value 1.48B
Trailing P/E (ttm) -13.2
Forward P/E -
PEG ratio -0.02
Price/Sales (ttm) 37.24
Price/Book (mrq) 3.08
Enterprise Value/Revenue 34.42
Enterprise Value/EBITDA -11.97
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.42M
Average volume (90 days) 1.05M
Price summary
52-Week low 4.12
52-Week high 25.77
Beta -
50-Day moving average 19.95
200-Day moving average 19.02
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -3.03%
Operating margin -3.45%
Operational effectiveness
Return on assets -0.18%
Return on equity -0.41%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.66
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.98
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 10.16
Total debt (mrq) -
Total Debt/Equity (mrq) 0.07
Current ratio (mrq) 9.54%
Book value per share (mrq) 7.96
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
